Commodore Capital Lp - Nov 24, 2021 Form 4 Insider Report for Satsuma Pharmaceuticals, Inc. (STSA)

Role
10%+ Owner
Signature
/s/ Michael Kramarz, Managing Partner
Stock symbol
STSA
Transactions as of
Nov 24, 2021
Transactions value $
$15,837
Form type
4
Date filed
11/29/2021, 03:30 PM
Previous filing
Nov 23, 2021
Next filing
Nov 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STSA Common Stock, par value $0.0001 per share Purchase $15.8K +2.92K +0.08% $5.42 3.71M Nov 24, 2021 By Commodore Capital Master LP F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held directly by Commodore Capital Master LP ("Commodore Master"). Commodore Capital LP ("Commodore Capital") is the investment manager to Commodore Master. Michael Kramarz and Robert Egen Atkinson are the managing partners of Commodore Capital and exercise investment and dispositive power over the securities held by Commodore Master. Each of Commodore Capital, Mr. Kramarz and Mr. Atkinson disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that Commodore Capital, Commodore Master, Mr. Kramarz and Mr. Atkinson or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.37 to $5.50 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.